Detalhe da pesquisa
1.
Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients With Systemic Autoimmune Rheumatic Diseases.
J Rheumatol
; 51(3): 305-312, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839812
2.
Factors Associated With an Electronic Health Record-Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease.
J Rheumatol
; 51(5): 529-537, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38428964
3.
Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases.
Ann Rheum Dis
; 82(4): 565-573, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442978
4.
Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study.
Rheumatology (Oxford)
; 2023 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38070152
5.
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status.
Rheumatology (Oxford)
; 62(4): 1621-1626, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124987
6.
A Women in Medicine Trainees' Council: a model for women trainee professional development.
Postgrad Med J
; 99(1168): 79-82, 2023 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36841227
7.
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave.
Ann Rheum Dis
; 81(12): 1742-1749, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944947
8.
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance.
Ann Rheum Dis
; 81(7): 970-978, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172961
9.
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.
Ann Rheum Dis
; 80(9): 1137-1146, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049860
10.
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study.
Ann Rheum Dis
; 83(5): 680-682, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38199795
11.
Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases.
Ann Rheum Dis
; 81(2): 289-291, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34489304
12.
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial.
Lancet Rheumatol
; 6(1): e21-e30, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258675
13.
Baseline Glucocorticoid-Related Toxicity Scores in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial.
ACR Open Rheumatol
; 5(1): 51-58, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36604825
14.
The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A1c During the Treatment of Giant Cell Arteritis.
Arthritis Rheumatol
; 75(4): 586-594, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36383175
15.
Glucocorticoid Toxicity Index scores by domain in patients with antineutrophil cytoplasmic antibody-associated vasculitis treated with avacopan versus standard prednisone taper: post-hoc analysis of data from the ADVOCATE trial.
Lancet Rheumatol
; 5(3): e130-e138, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38251609
16.
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines Against COVID-19 Infection Among Patients With Systemic Autoimmune Rheumatic Diseases on Immunomodulatory Medications.
J Rheumatol
; 50(5): 697-703, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642428
17.
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study.
Semin Arthritis Rheum
; 58: 152108, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36347211
18.
Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study.
Semin Arthritis Rheum
; 63: 152286, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37913612
19.
The Glucocorticoid Toxicity Index-Metabolic Domains, an abridged version of the Glucocorticoid Toxicity Index: post-hoc analysis of data from the ADVOCATE trial.
Lancet Rheumatol
; 5(7): e413-e421, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38251552
20.
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study.
Lancet Rheumatol
; 5(3): e139-e150, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36844970